'Bacterial conjunctivitis drugs fluoroquinolones' presentation slideshows

Global U.s Bacterial Conjunctivitis Drugs Market - Size, Share, Analysis, Trends to 2024

The U.S. bacterial conjunctivitis drugs market has been segmented based on drug classes most commonly used for the respective treatment. Based on the same, the market has been segmented into fluoroquinolones, aminoglycosides, macrolides and others. Fluoroquinolones market for bacterial conjunctivitis has been further studied for ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, gatifloxacin and besifloxacin. Aminolgycosides are further segmented into tobramycin and gentamycin. Similarly, erythromycin and azithromycin together represent the macrolides segment.

316 views • 14 slides